Definitive Analysis
Financial Statements
Periods / Units
Fundamentals
Valuations
Miscellaneous
Analysis Mode
Full Access
See Pricing Start Trial
Multiples Valuation: Agilent Technologies, Inc.

Agilent Technologies, Inc. (A)

Industry: Medical - Diagnostics & Research Model: Peers Multiples Valuation

Valuation Snapshot

Winsorized Fair Value
Range (Low - High) $66.12 — $109.91
Selected (Average) $91.50
Upside to Live -34.48%
Full Range Fair Value
Range (Low - High) $75.56 — $116.01
Selected (Average) $98.24
Upside to Live -29.65%
Live Price $139.64

Industry Peers Data

TickerRankNameRev TTM (M) Trailing P/EForward P/ETrailing EV/EBITDAForward EV/EBITDATrailing EV/EBITForward EV/EBIT
DHR 2 Danaher Corporatio 24,268 37.50 36.90 21.37 20.55 31.78 25.17
0QNO.L 3 Lonza Group AG 17,336 30.36 21.83 12.02 8.64 17.57 13.17
IQV 4 IQVIA Holdings Inc 15,904 25.20 16.94 13.31 11.89 20.66 16.33
SHL.AX 5 Sonic Healthcare L 12,270 12.59 11.77 5.99 5.16 2.85 2.78
ESF.VI 6 Eurofins Scientifi 12,203 21.20 21.20 7.66 7.66 5.39 9.29
DGX 7 Quest Diagnostics 10,850 22.03 22.60 12.77 12.56 17.68 17.85
IDHC.L 8 Integrated Diagnos 9,048 9.06 7.63 4.99 4.14 5.49 4.96
A 9 Agilent Technologi 6,948 31.79 28.22 23.43 21.62 24.26 25.99
603259.SS 10 WuXi AppTec Co., L 5,887 14.18 10.09 9.76 6.93 8.03 6.90
SYNH 11 Syneos Health, Inc 5,419 61.34 61.34 14.50 14.37 42.53 24.71
ILMN 12 Illumina, Inc. 4,287 20.39 19.99 12.25 11.75 17.16 19.07
IDXX 13 IDEXX Laboratories 4,167 49.81 43.08 35.28 30.68 36.09 33.84
CRL 14 Charles River Labo 4,024 - - 19.32 20.43 18.64 87.76
WAT 15 Waters Corporation 3,106 26.76 25.45 17.61 16.47 23.93 21.06
EXAS 16 Exact Sciences Cor 3,082 - - - - - -
SYAB.DE 17 Synlab AG 3,071 27.70 27.70 7.78 7.78 17.44 27.50

Implied Valuation Analysis

Line Item Trailing P/EForward P/ETrailing EV/EBITDAForward EV/EBITDATrailing EV/EBITForward EV/EBIT
Winsorized Median Multiple22.0321.2012.1310.2017.5017.09
Full Range Median Multiple25.2021.8312.5111.8217.6218.46
Industry Multiple27.5525.1213.9012.7918.9522.17
Market Implied Multiple30.3326.9322.3920.6623.1824.84
Company (A) Multiple31.7928.2223.4321.6224.2625.99
(*) Net Income / EBITDA / Revenue1,3031,4681,8351,9881,7721,654
Winsorized Enterprise ValueN/AN/A22,26420,27631,01428,262
Full Range Median Enterprise ValueN/AN/A22,94823,50031,22930,524
(-) Net Debt1,5651,5651,5651,5651,5651,565
Winsorized Equity Value28,70231,10520,69918,71129,44926,697
Full Range Median Equity Value32,83232,03821,38321,93529,66428,959
(/) Shares Outstanding283283283283283283
Winsorized Fair Value$101.42$109.91$73.14$66.12$104.06$94.34
Full Range Median Fair Value$116.01$113.21$75.56$77.51$104.82$102.33
Current Price$139.64$139.64$139.64$139.64$139.64$139.64
Upside / Downside-27.37%-21.29%-47.62%-52.65%-25.48%-32.44%
Safety Margin30.0%30.0%30.0%30.0%30.0%30.0%
Buy Price$70.99$76.94$51.20$46.28$72.84$66.04
Buy / Don't BuyDon’t BuyDon’t BuyDon’t BuyDon’t BuyDon’t BuyDon’t Buy